| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
119,920,000 |
| Market
Cap: |
2.48(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.96 - $32.96 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
97,506 |
194,997 |
252,199 |
526,275 |
| Total Sell Value |
$1,994,341 |
$3,816,456 |
$5,294,638 |
$13,483,252 |
| Total People Sold |
2 |
5 |
5 |
6 |
| Total Sell Transactions |
4 |
19 |
38 |
76 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nelsen Robert |
Director |
– • • |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
2,030 |
|
- |
|
| Nelsen Robert |
Director |
– • • |
2019-08-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
10,668,749 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-08-07 |
4 |
AS |
$18.81 |
$141,075 |
I/I |
(7,500) |
617,589 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$20.21 |
$222,825 |
I/I |
(10,989) |
79,934 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$19.93 |
$132,187 |
D/D |
(6,511) |
4,081 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
OE |
$5.28 |
$34,378 |
D/D |
6,511 |
7,988 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-07-08 |
4 |
AS |
$20.25 |
$152,135 |
I/I |
(7,500) |
625,089 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-07-01 |
4 |
AS |
$20.76 |
$380,593 |
I/I |
(18,333) |
2,502,638 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-06-10 |
4 |
AS |
$18.77 |
$140,775 |
I/I |
(7,500) |
632,589 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.78 |
$241,943 |
I/I |
(12,883) |
90,923 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.62 |
$86,711 |
D/D |
(4,617) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
OE |
$5.28 |
$24,378 |
D/D |
4,617 |
3,906 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-06-03 |
4 |
AS |
$19.07 |
$349,610 |
I/I |
(18,333) |
2,560,971 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-05-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,520,971 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-13 |
4 |
AS |
$21.09 |
$52,725 |
I/I |
(2,500) |
640,089 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-10 |
4 |
AS |
$22.19 |
$55,475 |
I/I |
(2,500) |
642,589 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.16 |
$73,483 |
I/I |
(3,316) |
103,806 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.17 |
$56,445 |
D/D |
(2,546) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
OE |
$5.28 |
$13,443 |
D/D |
2,546 |
2,546 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$57,150 |
I/I |
(2,500) |
645,089 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.83 |
$73,438 |
I/I |
(3,210) |
107,122 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$60,792 |
D/D |
(2,653) |
0 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
OE |
$5.28 |
$14,008 |
D/D |
2,653 |
2,653 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.50 |
$61,406 |
D/D |
(2,613) |
0 |
|
- |
|
426 Records found
|
|
Page 13 of 18 |
|
|
0.29 (1.42%) 
